Trial intelligence / Profile preview

Jidan Dispersible Tablets for Cough and Sputum due to Respiratory Infections

CTR20131871Phase 3Active

Sponsor
Jilin Province Qixingshan Pharmaceutical
Start
Apr 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Jidan Dispersible Tablets in upper respiratory infection (URI), acute bronchitis, chronic bronchitis (CB), pneumonia, sponsored by Jilin Province Qixingshan Pharmaceutical. Started Apr 2014; status: active.

02

Drugs

Jidan Dispersible Tablets
03

Conditions

upper respiratory infection (URI)acute bronchitischronic bronchitis (CB)pneumonia

Beyond the preview

Go deeper on CTR20131871.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20131871.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call